Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies. - Ramakrishnan V; Bender B; Langenhorst J; Magnusson MO; Dolton M; Shim J; Fuji RN; Monteiro C; Teng E; Kassir N; Jin J (The journal of prevention of Alzheimer's disease, 2024)